Cargando…

Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial

Vitamin D deficiency, persistent hyperparathyroidism, and bone loss are common after kidney transplantation (KTx). However, limited evidence exists regarding the effects of cholecalciferol supplementation on parathyroid hormone (PTH) and bone loss after KTx. In this prespecified secondary endpoint a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsujita, Makoto, Doi, Yohei, Obi, Yoshitsugu, Hamano, Takayuki, Tomosugi, Toshihide, Futamura, Kenta, Okada, Manabu, Hiramitsu, Takahisa, Goto, Norihiko, Isaka, Yoshitaka, Takeda, Asami, Narumi, Shunji, Watarai, Yoshihiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298992/ https://www.ncbi.nlm.nih.gov/pubmed/34747516 http://dx.doi.org/10.1002/jbmr.4469

Ejemplares similares

The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study
por: Doi, Yohei, et al.
Publicado: (2021)

Preoperative Comorbidities and Outcomes of Medically Complex Living Kidney Donors
por: Hiramitsu, Takahisa, et al.
Publicado: (2019)

Pre-operative Localisation of the Parathyroid Glands in Secondary Hyperparathyroidism: A Retrospective Cohort Study
por: Hiramitsu, Takahisa, et al.
Publicado: (2019)

Hand-Assisted Laparoscopic Donor Nephrectomy in Living Donors with a History of Abdominal Surgery: A Retrospective Cohort Study
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Long‐term prognosis in kidney transplant recipients with human T‐cell leukemia virus type 1 infection
por: Goto, Norihiko, et al.
Publicado: (2020)

Intact parathyroid hormone levels localize causative glands in persistent or recurrent renal hyperparathyroidism: A retrospective cohort study
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Intraoperative recurrent laryngeal nerve monitoring using endotracheal electromyography during parathyroidectomy for secondary hyperparathyroidism
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Hand port-site infection after hand-assisted laparoscopic donor nephrectomy for living-donor kidney transplantation: a retrospective cohort study
por: Hiramitsu, Takahisa, et al.
Publicado: (2022)

Oral/oesophageal candidiasis is a risk factor for severe infection after kidney transplantation
por: Abe, Tetsuya, et al.
Publicado: (2021)

Adult Living-Donor Kidney Transplantation, Donor Age, and Donor–Recipient Age
por: Hiramitsu, Takahisa, et al.
Publicado: (2021)

Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak
por: Goto, Norihiko, et al.
Publicado: (2015)

Impact of grafting using thin upper pole artery ligation on living-donor adult kidney transplantation: The STROBE study
por: Hiramitsu, Takahisa, et al.
Publicado: (2016)

Impact of Arterial Reconstruction With Recipient's Own Internal Iliac Artery for Multiple Graft Arteries on Living Donor Kidney Transplantation: Strobe Study
por: Hiramitsu, Takahisa, et al.
Publicado: (2015)

Clinical Significance of Shared T Cell Epitope Analysis in Early De Novo Donor-Specific Anti-HLA Antibody Production After Kidney Transplantation and Comparison With Shared B cell Epitope Analysis
por: Tomosugi, Toshihide, et al.
Publicado: (2021)

Elevated parathyroid hormone one year after kidney transplantation is an independent risk factor for graft loss even without hypercalcemia
por: Okada, Manabu, et al.
Publicado: (2022)

Persistent hyperparathyroidism after preemptive kidney transplantation
por: Okada, Manabu, et al.
Publicado: (2023)

The effect of maintaining high hemoglobin levels on long-term kidney function in kidney transplant recipients: a randomized controlled trial
por: Tsujita, Makoto, et al.
Publicado: (2019)

Intraoperative intact parathyroid hormone monitoring and frozen section diagnosis are essential for successful parathyroidectomy in secondary hyperparathyroidism
por: Hiramitsu, Takahisa, et al.
Publicado: (2022)

Treatment for secondary hyperparathyroidism focusing on parathyroidectomy
por: Hiramitsu, Takahisa, et al.
Publicado: (2023)

Maximal parathyroid gland diameter as a predictive factor for autograft-dependent recurrent secondary hyperparathyroidism after total parathyroidectomy
por: Hiramitsu, Takahisa, et al.
Publicado: (2023)

Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial
por: Obi, Yoshitsugu, et al.
Publicado: (2020)

Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of Pneumocystis jirovecii Pneumonia in Kidney Transplant Recipients
por: Goto, Norihiko, et al.
Publicado: (2017)

Prediction models for the recipients’ ideal perioperative estimated glomerular filtration rates for predicting graft survival after adult living-donor kidney transplantation
por: Hiramitsu, Takahisa, et al.
Publicado: (2023)

Virus-Associated Hemophagocytic Syndrome in Renal Transplant Recipients: Report of 2 Cases from a Single Center
por: Nanmoku, Koji, et al.
Publicado: (2015)

Analysis of T and B Cell Epitopes to Predict the Risk of de novo Donor-Specific Antibody (DSA) Production After Kidney Transplantation: A Two-Center Retrospective Cohort Study
por: Sakamoto, Shintaro, et al.
Publicado: (2020)

Prevalence and Prognostic Implications of Vitamin D Deficiency in Chronic Kidney Disease
por: Obi, Yoshitsugu, et al.
Publicado: (2015)

Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial
por: Pérez‐Castrillón, José Luis, et al.
Publicado: (2021)

Predictors of Bone Mineral Density Improvement after Parathyroidectomy for Secondary Hyperparathyroidism: A Retrospective Single-Center Analysis
por: Okada, Manabu, et al.
Publicado: (2021)

A randomized clinical trial of vitamin D(3) (cholecalciferol) in ulcerative colitis patients with hypovitaminosis D(3)
por: Mathur, Jagrati, et al.
Publicado: (2017)

Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS‐R trials
por: Neal, Bruce, et al.
Publicado: (2017)

Optimized vitamin D repletion with oral thin film cholecalciferol in patients undergoing stem cell transplant
por: Bartlett, Allison L., et al.
Publicado: (2023)

A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints
por: Mozgunov, Pavel, et al.
Publicado: (2019)

Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions
por: Anker, Stefan D., et al.
Publicado: (2022)

Patient preference for second and third line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study
por: Shields, Beverley M, et al.
Publicado: (2023)

Galactose-deficient IgA1 Is Involved in IgA Deposition in Renal Grafts Biopsied One Hour after Kidney Transplantation
por: Kuroyanagi, Yuki, et al.
Publicado: (2022)

2304: Identifying optimal multiple sclerosis (MS)-specific atrophy markers as primary endpoint for Phase II s in progressive MS
por: Azevedo, Christina, et al.
Publicado: (2018)

TOPCAT misses its primary endpoint: Should spironolactone be abandoned in HFpEF?
por: ElGuindy, Ahmed M.
Publicado: (2013)

The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
por: Smelt, Hendrika J.M., et al.
Publicado: (2019)

Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
por: Sosa Henríquez, Manuel, et al.
Publicado: (2020)

Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline
por: Hamano, Takayuki, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vru2aor50edvlih8ngcredeb23